Hepatitis E seroprevalence in a German cohort of patients with inflammatory bowel diseases.

by Peter Hoffmann, Rouven Behnisch, Julia Gsenger, Paul Schnitzler, Annika Gauss
Published 2020-01-01

Gene Polymorphisms of NOD2, IL23R, PTPN2 and ATG16L1 in Patients with Crohn’s Disease: On the Way to Personalized Medicine?

by Peter Hoffmann, David Lamerz, Petra Hill, Marietta Kirchner, Annika Gauss
Published 2021-06-01

Higher Levels of Psychological Burden and Alterations in Personality Functioning in Crohn’s Disease and Ulcerative Colitis

by Felicitas Engel, Sabrina Berens, Sabrina Berens, Annika Gauss, Rainer Schaefert, Rainer Schaefert, Wolfgang Eich, Jonas Tesarz
Published 2021-06-01

Patients with Multiple Functional Gastrointestinal Disorders (FGIDs) Show Increased Illness Severity: A Cross-Sectional Study in a Tertiary Care FGID Specialty Clinic

by Sabrina Berens, Felicitas Engel, Annika Gauss, Jonas Tesarz, Wolfgang Herzog, Beate Niesler, Esther Stroe-Kunold, Rainer Schaefert
Published 2020-01-01

Tofacitinib in Treatment-Refractory Moderate to Severe Ulcerative Colitis: Real-World Experience from a Retrospective Multicenter Observational Study

by Peter Hoffmann, Anna-Maria Globig, Anne K. Thomann, Maximilian Grigorian, Johannes Krisam, Peter Hasselblatt, Wolfgang Reindl, Annika Gauss
Published 2020-07-01